Treatment of graft failure with fludarabine (Flu), antithymocyte globulin (ATG) and a second allogeneic stem cell transplantation (SCT).

被引:0
|
作者
Jabbour, EJ [1 ]
Shahjahan, M [1 ]
Rondon, G [1 ]
Anderlini, P [1 ]
Giralt, S [1 ]
Couriel, DR [1 ]
Champlin, RE [1 ]
Khouri, IF [1 ]
机构
[1] MD Anderson Canc Ctr, Houston, TX USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2734
引用
收藏
页码:767A / 767A
页数:1
相关论文
共 50 条
  • [21] ANTITHYMOCYTE GLOBULIN (ATG) DOSAGE AND GRAFT SURVIVAL IN RENAL-TRANSPLANTATION
    KOUNTZ, SL
    BUTT, KHM
    RAO, TKS
    ZIELINSKI, CM
    RAFI, M
    SCHULTZ, JR
    TRANSPLANTATION PROCEEDINGS, 1977, 9 (01) : 1023 - 1025
  • [22] Evaluation of early toxicity of rabbit anti thymocyte globulin (Thymoglobuline®, ATG) for preparation of allogeneic stem cell transplantation (SCT).
    Ionescu, I
    Rocha, V
    Chevret, S
    Buffet, R
    Rafii, H
    Gluckman, E
    BLOOD, 1999, 94 (10) : 357B - 357B
  • [23] SECOND ALLOGENEIC STEM CELL TRANSPLANTATION (SCT) IN PEDIATRIC PATIENTS
    Ayas, M.
    Al-Jefri, A.
    Eldali, A.
    Al-seraihi, A.
    Al-Mahr, M.
    Al-Ghonaium, A.
    Al-Ahmari, A.
    Al-Mousa, H.
    Al-Mohsen, S.
    Al-Dhekri, H.
    El-Solh, H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 78 - 79
  • [24] Fludarabine, Low Dose Busulfan and Antithymocyte Globulin (ATG) Compared to Fludarabine and Low Dose Total Body Irradiation (TBI) for Reduced-Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) In Patients with Lymphoid Malignancies
    Malard, Florent
    Brissot, Eolia
    Chevallier, Patrice
    Guillaume, Thierry
    Delaunay, Jacques
    Ayari, Sameh
    Mahe, Beatrice
    Dubruille, Viviane
    Gastinne, Thomas
    Blin, Nicolas
    Saulquin, Beatrice
    Harousseu, Jean Luc
    Moreau, Philippe
    Milpied, Noel
    Le Gouill, Steven
    Mohty, Mohamad
    BLOOD, 2010, 116 (21) : 1426 - 1427
  • [25] Similar outcome after related or unrelated allogeneic stem cell transplantation following reduced conditioning with fludarabine, busulfan, and antithymocyte globulin
    Vigouroux, S.
    Tabrizi, R.
    Melot, C.
    Coiffard, J.
    Lafarge, X.
    Marit, G.
    Pigneux, A.
    Leguay, T.
    Dilhuydy, M. S.
    Schmitt, A.
    Boiron, J.
    Milpied, N.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S296 - S296
  • [26] Reduced-intensity conditioning with fludarabine, low-dose busulfan and antithymocyte globulin prior to allogeneic stem cell transplantation
    Malard, F.
    Brissot, E.
    Delaunay, J.
    Ayari, S.
    Guillaume, T.
    Chevallier, P.
    Dubruille, V.
    Mahe, B.
    Blin, N.
    Gastinne, T.
    Le Gouill, S.
    Saulquin, B.
    Harousseau, J. L.
    Moreau, P.
    Milpied, N.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S290 - S290
  • [27] Fludarabine, Antithymocyte Globulin and Low Dose Cyclophosphamide As Conditioning Regimen for Allogeneic Stem Cell Transplantation in Children with Severe Aplastic Anemia
    Essa, Mohammed F.
    Al Sudany, Reem
    Al Afghani, Sameera
    Jarrar, Mohammad
    Alsultan, Abdulrahman S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S243 - S243
  • [28] Hepatotoxicity following antithymocyte globulin treatment in allogeneic haematopoietic stem cell transplantation: about five cases
    Lebrun-Vignes, B.
    Touzeau, C.
    Damasse, J.
    Garnier, A.
    Nguyen, S.
    Callot, D.
    Warot, D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 25 - 25
  • [29] NK cell predicts the severity of acute graft-versus-host disease in patients after allogeneic stem cell transplantation using antithymocyte globulin (ATG) in pretreatment scheme
    Zhang, Ping
    Yang, Shujun
    Zou, Yujing
    Yan, Xiao
    Wu, Hao
    Zhou, Miao
    Sun, Yong Cheng
    Zhang, Yi
    Zhu, Huiling
    Xu, Kaihong
    Wang, Yi
    Sheng, Li Xia
    Mu, Qitian
    Sun, Liguang
    Ouyang, Guifang
    BMC IMMUNOLOGY, 2019, 20 (01)
  • [30] NK cell predicts the severity of acute graft-versus-host disease in patients after allogeneic stem cell transplantation using antithymocyte globulin (ATG) in pretreatment scheme
    Ping Zhang
    Shujun Yang
    Yujing Zou
    Xiao Yan
    Hao Wu
    Miao Zhou
    Yong Cheng Sun
    Yi Zhang
    Huiling Zhu
    Kaihong Xu
    Yi Wang
    Li Xia Sheng
    Qitian Mu
    Liguang Sun
    Guifang Ouyang
    BMC Immunology, 20